Fact CheckerSign in

NCT07498114Completed

Association Between Fatigue Severity and Health-Related Quality of Life in Individuals With Stroke

Fatigue Severity Independently Predicts Health-Related Quality of Life in Stroke Survivors: A Cross-Sectional Study

Source: ClinicalTrials.gov · Last updated 30 Mar 2026

Brief summary (registry, in English)

This observational cross-sectional study aims to examine the association between fatigue severity and health-related quality of life in individuals with stroke. Fatigue severity will be assessed using the Fatigue Severity Scale (FSS), and quality of life will be evaluated using the Nottingham Health Profile (NHP). The primary analysis will investigate the relationship between FSS total score and NHP total score and domain scores.

Status (registry)
Completed
Study type
Observational
Enrollment
53 (actual)
First submitted
23 Mar 2026
Start date
5 Mar 2026
Primary completion date
25 Mar 2026
Lead sponsor
Uskudar University
Diseases
Stroke
NCT number
NCT07498114

What you commit to

  • Study type: Observational
  • Participants enrolled: 53
  • From 5 Mar 2026 to the primary completion date, 25 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \-

Who the study is looking for

  • Time since stroke: ≥ \[3\] months
  • Able to understand and complete questionnaires (with/without assistance)
  • Provides informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Üsküdar Üniversitesi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.